The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Characterizing the immune effects of enfortumab vedotin (EV) on peripheral blood mononuclear cells (PBMCs) in metastatic urothelial cancer patients (mUC).
 
Aditi Gupta
Stock and Other Ownership Interests - Held through broad basket ETF/ mutual fund
 
Carlo Sevilla
No Relationships to Disclose
 
Nicole Pihlstrom
No Relationships to Disclose
 
Stanley Liang
Employment - Memorial Sloan-Kettering Cancer Center
 
Ashley Regazzi
No Relationships to Disclose
 
Asia McCoy
Consulting or Advisory Role - Astellas Pharma
 
Colleen Maher
No Relationships to Disclose
 
Phillip Wong
Patents, Royalties, Other Intellectual Property - Receive small annual royalty payments from the University of Washington for a monoclonal antibody that was developed during my graduate studies there.
 
Firas Ahmed
No Relationships to Disclose
 
Samuel Funt
Employment - ByHeart (I)
Stock and Other Ownership Interests - 76Bio (I); Allogene Therapeutics; Doximity; IconOVir Bio (I); Kite, a Gilead company; Kronos Bio; Neogene Therapeutics (I); Urogen pharma (I); Vida Ventures (I)
Consulting or Advisory Role - BioNtech; Immunai; Merck
Research Funding - ALX Oncology (Inst); AstraZeneca (Inst); Decibel Therapeutics (Inst); Genentech/Roche (Inst); Merck (Inst)
Travel, Accommodations, Expenses - AstraZeneca/MedImmune; Bristol-Myers Squibb
 
Gopa Iyer
Consulting or Advisory Role - AstraZeneca; Bicycle Therapeutics; Flare Therapeutics; Janssen; Loxo/Lilly; Mirati Therapeutics
Research Funding - Bayer (Inst); Debiopharm Group (Inst); Janssen (Inst); Mirati Therapeutics (Inst); Novartis (Inst); Seagen (Inst)
 
Dean Bajorin
Consulting or Advisory Role - Bristol Myers Squibb Foundation; Merck
Research Funding - Astellas Pharma (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Merck (Inst); Novartis (Inst); Seattle Genetics/Astellas (Inst)
 
Min Yuen Teo
Consulting or Advisory Role - AstraZeneca; Janssen Oncology
Research Funding - Astellas Pharma (Inst); Bristol-Myers Squibb (Inst); Clovis Oncology (Inst); Pharmacyclics (Inst)
 
Jonathan Rosenberg
Honoraria - Clinical Care Options; MashupMD; Medical Educator Consortium; Medscape; MJH Life Sciences; NCCN/Pfizer; Peerview; Pfizer; Physicans' Education Resource; Research To Practice; Touch Oncology; UpToDate
Consulting or Advisory Role - Aktis Oncology; Astellas Pharma; AstraZeneca; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Century Therapeutics; EMD Serono; Generate Biomedicines; Gilead Sciences; Janssen Oncology; Lilly; Merck; Mirati Therapeutics; Pfizer; Roche/Genentech; Samsung Bioepis; Seagen; Tyra Biosciences
Research Funding - Acrivon Therapeutics; Astellas Pharma (Inst); AstraZeneca (Inst); Bayer (Inst); Genentech/Roche (Inst); Lilly; Seagen (Inst)
Patents, Royalties, Other Intellectual Property - Amplification of chromosome 1q23 to predict cancer outcomes (Inst); Predictor of platinum sensitivity (Inst)
Travel, Accommodations, Expenses - Seagen
(OPTIONAL) Uncompensated Relationships - Alliance for Clinical Trials in Oncology
 
Juan Osorio
No Relationships to Disclose
 
David Aggen
Consulting or Advisory Role - Adaptimmune; Alphasights; Aptitude Health; Astellas Pharma; Boehringer Ingelheim; Bristol Myers Squibb Foundation; Century Therapeutics; Curio Science; Guidepoint Global Advisors; MJH Life Sciences; Pfizer; Pfizer; Seagen
Patents, Royalties, Other Intellectual Property - University of Illinois - Urbana Champaign